课题基金 / 基金详情

Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)

Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
批准号：
435603
负责人：
Han Kathy
金额：
$78.86万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
未结题
起止时间：
2020-10-01 至 2026-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=435603&lang=en
关键词：
Clinical Trial De-Escalation Therapy Decisional Conflict Endometrial Cancer Molecular Biomarker P53/Tp53 Personalized Cancer Treatment Pole Quality Of Life Translational Research

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Endometrial cancer (EC) is diagnosed in >60,000 North American women each year. Unlike other cancers where advanced tumors can be reliably distinguished pathologically based on their appearance under the microscope, ECs are very difficult to tell apart. C
期刊论文(0)
专著(0)
科研奖励(0)
会议论文